Bacillus Calmette-Guérin (BCG) therapy lowers the incidence of Alzheimer’s disease in bladder cancer patients

BACKGROUND: Alzheimer’s disease (AD) affects one in ten people older than 65 years. Thus far, there is no cure or even disease-modifying treatment for this disease. The immune system is a major player in the pathogenesis of AD. Bacillus Calmette-Guérin (BCG), developed as a vaccine against tuberculo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gofrit, Ofer N., Klein, Benjamin Y., Cohen, Irun R., Ben-Hur, Tamir, Greenblatt, Charles L., Bercovier, Hervé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837488/
https://www.ncbi.nlm.nih.gov/pubmed/31697701
http://dx.doi.org/10.1371/journal.pone.0224433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837488/
https://www.ncbi.nlm.nih.gov/pubmed/31697701
http://dx.doi.org/10.1371/journal.pone.0224433

Ejemplares similares